Share chart Tenaya Therapeutics, Inc.
Extended chart
Simple chart
About Tenaya Therapeutics, Inc.
Tenaya Therapeutics, Inc. разрабатывает препараты для лечения сердечной недостаточности. Он предлагает платформу клеточной регенерации, которая позволяет in vivo перепрограммировать сердечные фибробласты в кардиомиоциты путем доставки запатентованных факторов транскрипции; платформа генной терапии, позволяющая целенаправленно доставлять полезную нагрузку к сердечным фибробластам; и платформа точной медицины, которая обеспечивает индивидуальный подход к лечению сердечных заболеваний. Компания была зарегистрирована в 2016 году и базируется в Южном Сан-Франциско, Калифорния.| IPO date | 2021-07-30 |
|---|---|
| ISIN | US87990A1060 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.tenayatherapeutics.com |
| Цена ао | 0.6003 |
| Change price per day: | +11.64% (0.6003) |
|---|---|
| Change price per week: | +47.3% (0.455) |
| Change price per month: | -25.33% (0.8975) |
| Change price per 3 month: | -75.63% (2.75) |
| Change price per half year: | -66.32% (1.99) |
| Change price per year: | -86.53% (4.975) |
| Change price per 3 year: | -93.4% (10.15) |
| Change price per 5 year: | -0% (0.6702) |
| Change price per 10 year: | -0% (0.6702) |
| Change price per year to date: | -57.85% (1.59) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Column Group LLC | 9 | 11.97 |
| Casdin Capital, LLC | 7 | 8.58 |
| Blackrock Inc. | 5 | 5.99 |
| Price (T.Rowe) Associates Inc | 3 | 4.26 |
| FMR, LLC | 3 | 3.71 |
| Vanguard Group Inc | 3 | 3.65 |
| Octagon Capital Advisors LP | 3 | 3.63 |
| Integral Health Asset Management, LLC | 2 | 2.87 |
| Citadel Advisors Llc | 2 | 2.86 |
| VR Adviser, LLC | 2 | 1.98 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| iShares Micro-Cap ETF | 0.0295 | 17.09 | 1.54048 |
| Avantis U.S Small Cap Equity ETF | 0.01822 | 27.77 | 1.68271 |
| Vanguard Russell 2000 ETF | 0.01 | 17.16 | 1.48801 |
ProShares UltraPro Russell2000
|
0.00254 | 89.82 | 1.47873 |
iShares Russell 2000 Growth ETF
|
0.00246 | 38.04 | 0.6026 |
| ProShares Hedge Replication ETF | 0.00068 | 5.92 | 1.47892 |
| Dimensional U.S. Targeted Value ETF | 0.00035 | 26.01 | 1.93487 |
| iShares Russell 3000 ETF | 0.00023 | 24.83 | 1.43482 |
| Avantis U.S. Equity ETF | 0.0001 | 23.04 | 1.59151 |
| Vanguard Russell 3000 ETF | 0 | 31.87 | 1.43817 |
| Vanguard Russell 2000 Growth ETF | 0 | 23.05 | 0.60264 |
| 0.01 | 29.51 | 1.39 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Faraz Ali M.B.A. | CEO & Director | 816.39k | 1973 (52 years) |
| Dr. Deepak Srivastava M.D. | Scientific Founder, Chairman of Scientific Advisory Board & Director | 118k | 1966 (59 years) |
| Dr. Eric N. Olson Ph.D. | Scientific Founder & Member of Scientific Advisory Board | N/A | |
| Dr. Bruce R. Conklin | Scientific Founder | N/A | |
| Dr. Benoit G. Bruneau Ph.D. | Scientific Founder | N/A | |
| Dr. Whittemore G. Tingley M.D., PH.D. | Chief Medical Officer | 621.98k | 1968 (57 years) |
| Dr. Saptarsi Haldar M.D. | Scientific Founder | N/A | |
| Dr. Sheng Ding Ph.D. | Scientific Founder | N/A | |
| Ms. Chihiro Saito | Senior Accounting & Financial Operations and Interim Principal Accounting Officer | 1966 (59 years) | |
| Dr. Kee-Hong Kim Ph.D. | Chief Technology Officer | 1966 (59 years) |
Address: United States, South San Francisco, CA , 171 Oyster Point Boulevard - open in Google maps, open in Yandex maps
Website: https://www.tenayatherapeutics.com
Website: https://www.tenayatherapeutics.com
